Drug Demand Reduction | INL23CA0064 PERU DRUGDEMAND 07192023

Opportunity Information: Apply for INL23CA0064 PERU DRUGDEMAND 07192023

The Drug Demand Reduction grant opportunity (Funding Opportunity Number INL23CA0064) is a discretionary U.S. Department of State, Bureau of International Narcotics and Law Enforcement Affairs (INL) program administered through U.S. Embassy Lima. It is designed to reduce drug use and drug-related offenses in Peru by strengthening the country s ability to prevent and treat substance use disorders, especially among communities that have historically had limited access to services. The award instrument is a cooperative agreement, meaning the U.S. government expects to remain actively involved in the program s direction and implementation rather than providing a fully hands-off grant.

At the center of the opportunity is a capacity-building approach that expands evidence-based prevention and treatment nationwide while prioritizing underserved and vulnerable groups. INL Lima aims to break the cycle that links substance use, crime, and incarceration by promoting treatment and counseling as alternatives to incarceration for eligible juvenile offenders. A key feature of the programming is the use of established international training frameworks: the Universal Prevention Curriculum (UPC) and Universal Treatment Curriculum (UTC). These curricula are used to standardize and professionalize services by training practitioners in methods that are research-backed and replicable, improving both quality of care and consistency across different regions.

A major emphasis of this competition is expanding access to substance abuse treatment in rural areas of Peru, where service gaps are often largest due to distance, limited clinical workforce, and fewer specialized facilities. The broader DDR portfolio in Peru already includes work through approximately 250 community mental health centers nationwide, and the opportunity seeks to build on that foundation by further developing local capacity, improving referral pathways, and ensuring that treatment can reach people outside major urban areas. The program also highlights targeted training for health professionals with a focus on populations that are frequently under-served or face stigma in health systems, including women and girls and the LGBTQI community.

Strategically, this grant aligns with Peru s Integrated Country Strategy, particularly Goal 2, which focuses on creating a more secure and equitable country and region, and Objective 4.2, which emphasizes expanding protections and inclusive opportunities for youth, women, gender and other minorities, and other historically marginalized populations. In practical terms, this framing signals that applicants should not only address clinical service delivery, but also demonstrate how their approach improves equity, inclusion, and protections for vulnerable groups while contributing to public safety outcomes by reducing drug-related offending and supporting alternatives to detention for juveniles when appropriate.

Eligible applicants include U.S.-based non-profit and non-governmental organizations, overseas-based non-profit and non-governmental organizations, and overseas-based private or state educational institutions. The opportunity was posted on July 19, 2023, with an original closing date of December 8, 2023. The award ceiling is up to USD 300,000. The competition begins with a statement of interest (SOI), which typically functions as an initial concept submission used to gauge fit with program priorities before requesting more detailed technical and budget proposals.

• The Bureau of International Narcotics-Law Enforcement in the law, justice and legal services sector is offering a public funding opportunity titled "Drug Demand Reduction" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 19.704.
• This funding opportunity was created on 2023-07-19.
• Applicants must submit their applications by 2023-12-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $300,000.00 in funding.
• Eligible applicants include: Others.

Apply for INL23CA0064 PERU DRUGDEMAND 07192023

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: